A share price of Ironwood Pharmaceuticals Inc [IRWD] is currently trading at $4.98, up 6.18%. An important factor to consider is whether the stock is rising or falling in short-term value. The IRWD shares have gain 15.28% over the last week, with a monthly amount drifted -26.66%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Ironwood Pharmaceuticals Inc [NASDAQ: IRWD] stock has seen the most recent analyst activity on August 08, 2024, when CapitalOne downgraded its rating to a Equal Weight and also revised its price target to $4 from $12. Previously, Craig Hallum started tracking the stock with Buy rating on January 17, 2024, and set its price target to $21. On December 14, 2023, Wells Fargo initiated with a Overweight rating and assigned a price target of $20 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $21 on November 09, 2023. JMP Securities initiated its recommendation with a Mkt Outperform and recommended $22 as its price target on September 28, 2023. CapitalOne started tracking with a Overweight rating for this stock on September 02, 2022, and assigned it a price target of $15. In a note dated April 22, 2022, Piper Sandler initiated an Overweight rating and provided a target price of $16 on this stock.
Ironwood Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $3.79 and $15.70. Currently, Wall Street analysts expect the stock to reach $15 within the next 12 months. Ironwood Pharmaceuticals Inc [NASDAQ: IRWD] shares were valued at $4.98 at the most recent close of the market. An investor can expect a potential return of 201.2% based on the average IRWD price forecast.
Analyzing the IRWD fundamentals
Trailing Twelve Months sales for Ironwood Pharmaceuticals Inc [NASDAQ:IRWD] were 400.56M which represents -12.09% decline. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at 0.31%, Pretax Profit Margin comes in at 0.22%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is -0.03 and Total Capital is 0.35. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -1.95.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.72 points at the first support level, and at 4.46 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.15, and for the 2nd resistance point, it is at 5.32.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Ironwood Pharmaceuticals Inc [NASDAQ:IRWD] is 3.92. On the other hand, the Quick Ratio is 3.92, and the Cash Ratio is 2.32. Considering the valuation of this stock, the price to sales ratio is 1.99 and price to earnings (TTM) ratio is 115.28.
Transactions by insiders
Recent insider trading involved John Minardo, Chief Legal Officer, that happened on Aug 12 ’24 when 9910.0 shares were sold. Principal Accounting Officer, Silver Ronald completed a deal on Aug 12 ’24 to sell 3107.0 shares. Meanwhile, Officer John Minardo bought 11726.0 shares on Aug 12 ’24.
